Chronic Lymphocytic Leukemia Responds to Dermal Chelation

Optimum Health, Natural Healthcare Center

Status: Unknown

Conditions: Chronic Lymphocytic Leukemia

Treatments: Device: Dermal Chelation; Dietary Supplement: Nutritional Therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT03495492

DCCLL2018

Details and patient eligibility

About

The purpose of this clinical trial is to identify 50 participants with Chronic Lymphocytic Leukemia (CLL) and follow their total white blood cell (WBC) counts and absolute lymphocyte counts after performing dermal chelation and administering nutritional therapy

Full description

The purpose of this clinical trial is to use dermal chelation and hair tissue analysis to identify 50 participants with CLL. The total wbc counts and absolute lymphocyte counts of these participants will be followed after serial dermal chelations and nutritional therapy.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of Chronic Lymphocytic Leukemia and has a toxic heavy metal load
• Toxic heavy metal load

Exclusion criteria

• Pregnant
• Pacemaker implants
• Organ transplant recipients
• Psychotic episodes or epileptic seizures

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Participants

Experimental group

Description:

Group receiving dermal chelation and nutritional therapy

Treatment:

Dietary Supplement: Nutritional Therapy

Device: Dermal Chelation